Gloster H M, Roenigk R K
Department of Dermatology, Mayo Clinic, Rochester, MN 55905.
J Am Acad Dermatol. 1995 Mar;32(3):436-41. doi: 10.1016/0190-9622(95)90065-9.
The documented presence of human papillomavirus DNA in the plume after carbon dioxide laser treatment of warts has raised questions about the risk of transmission of human papillomavirus to laser surgeons.
We sought to define more clearly the risks to surgeons of acquiring warts from the CO2 laser plume.
A comparative study was conducted between CO2 laser surgeons and two large groups of population-based control subjects (patients with warts in Olmsted County and at the Mayo Clinic from 1988 to 1992). Conclusions were drawn about the risks to surgeons of acquiring warts from the CO2 laser plume.
There was no significant difference (p = 0.569) between the incidence of CO2 laser surgeons with warts (5.4%) and patients with warts in Olmsted County from 1988 to 1992 (4.9%). There was a significant difference between the incidence of plantar (p = 0.004), nasopharyngeal (p = 0.001), and genital and perianal warts (p = 0.004) in the study group and in patients with warts treated at the Mayo Clinic from 1988 to 1992. No significant difference was found between physicians who had acquired warts and those who were wart free, on the basis of the failure to use gloves (p = 0.418), standard surgical masks (p = 0.748), laser masks (p = 0.418), smoke evacuators (p = 0.564), eye protection (p = 0.196), or full surgical gowns (p = 0.216). Finally, the incidence rates of surgeons with warts per 1000 person-years did not increase significantly (p = 0.951) as the length of time that the CO2 laser was used to treat warts increased.
When warts are grouped together without specification of anatomic site, CO2 laser surgeons are no more likely to acquire warts than a person in the general population. However, human papillomavirus types that cause genital warts seem to have a predilection for infecting the upper airway mucosa, and laser plume containing these viruses may represent more of a hazard to the surgeon.
二氧化碳激光治疗疣后,在羽流中检测到人类乳头瘤病毒DNA,这引发了关于人类乳头瘤病毒传播给激光外科医生风险的疑问。
我们试图更明确地界定外科医生因二氧化碳激光羽流感染疣的风险。
对二氧化碳激光外科医生与两组大型基于人群的对照对象(1988年至1992年在奥姆斯特德县和梅奥诊所的疣患者)进行了一项比较研究。得出了外科医生因二氧化碳激光羽流感染疣的风险结论。
二氧化碳激光外科医生患疣的发生率(5.4%)与1988年至1992年奥姆斯特德县疣患者的发生率(4.9%)之间无显著差异(p = 0.569)。研究组与1988年至1992年在梅奥诊所接受疣治疗的患者相比,足底疣(p = 0.004)、鼻咽疣(p = 0.001)以及生殖器和肛周疣(p = 0.004)的发生率存在显著差异。在是否患疣的医生之间,基于未使用手套(p = 0.418)、标准手术口罩(p = 0.748)、激光口罩(p = 0.418)、烟雾抽吸器(p = 0.564)、眼部防护(p = 0.196)或全套手术服(p = 0.216),未发现显著差异。最后,随着二氧化碳激光用于治疗疣的时间延长,每1000人年患疣外科医生的发生率未显著增加(p = 0.951)。
当不按解剖部位对疣进行分组时,二氧化碳激光外科医生感染疣的可能性并不比普通人群中的人更高。然而,导致生殖器疣的人类乳头瘤病毒类型似乎更易感染上呼吸道黏膜,含有这些病毒的激光羽流可能对外科医生构成更大危害。